SCHEMBL5133030

SCHEMBL5133030

CCN(CCO)c1[c]cccc1-c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 6/20 0.37
HSD17B10 Q99714 5/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 4/20 0.37
MAPT P10636 2/20 0.37
PDK2 Q15119 2/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
USP7 Q93009 1/20 0.35
GAA P10253 1/20 0.35
ALOX15 P16050 3/20 0.35
CYP2C19 P33261 3/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HDAC4 P56524 1/20 0.34
CYP2D6 P10635 2/20 0.34
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7487017 0.72 PGR (0.39) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL15655702 0.66 MEN1 (0.49) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL6608219 0.66 CYP3A4 (0.44) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL10626283 0.65 ALDH1A1 (0.64) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL23501957 0.63 USP7 (0.47) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL10795881 0.63 HDAC4 (0.54) ALDH1A1HPGDPDK2SMN1; SMN2HDAC4
SCHEMBL16016477 0.63 L3MBTL1 (0.53) CYP3A4ALDH1A1HPGDMAPTPDK2
SCHEMBL2184360 0.63 ALDH1A1 (0.44) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL1004649 0.62 ALDH1A1 (0.73) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL5318807 0.62 ALDH1A1 (0.52) CYP1A2CYP3A4HSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008020203-A1 PYRIDINYLQUINAZ0LINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS ASTRAZENECA AB (SE) 2008-02-21 WO disclosed